Published in Chest on March 01, 2003
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med (2011) 5.53
Exhaled nitric oxide measurements: clinical application and interpretation. Thorax (2006) 2.01
Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications. Chron Respir Dis (2009) 1.54
Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. Thorax (2003) 1.16
Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir Res (2006) 1.13
Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests. Thorax (2005) 0.99
Clinical application of exhaled nitric oxide measurement in pediatric lung diseases. Ital J Pediatr (2012) 0.98
Exhaled nitric oxide, lung function, and exacerbations in wheezy infants and toddlers. J Allergy Clin Immunol (2010) 0.97
The clinical potential of exhaled breath analysis for diabetes mellitus. Diabetes Res Clin Pract (2012) 0.96
Partitioned exhaled nitric oxide to non-invasively assess asthma. Respir Physiol Neurobiol (2008) 0.93
Role of nitric oxide and its metabolites as potential markers in lung cancer. Ann Thorac Med (2010) 0.90
Characterizing asthma from a drop of blood using neutrophil chemotaxis. Proc Natl Acad Sci U S A (2014) 0.89
Airways disease: phenotyping heterogeneity using measures of airway inflammation. Allergy Asthma Clin Immunol (2007) 0.87
Improving asthma during pregnancy with dietary antioxidants: the current evidence. Nutrients (2013) 0.83
Exhaled nitric oxide in diagnosis and management of respiratory diseases. Ann Thorac Med (2009) 0.81
Correlation of exhaled nitric oxide, nasal nitric oxide and atopic status: A cross-sectional study in bronchial asthma and allergic rhinitis. Lung India (2014) 0.78
Exhaled nitric oxide fraction as an add-on to ACQ-7 for not well controlled asthma detection. PLoS One (2013) 0.77
Subjects in a Population Study with High Levels of FENO Have Associated Eosinophil Airway Inflammation. ISRN Allergy (2011) 0.76
Irreversible airway obstruction assessed by high-resolution computed tomography (HRCT), exhaled nitric oxide (FENO), and biological markers in induced sputum in patients with asthma. Wien Klin Wochenschr (2014) 0.76
The clinical significance of exhaled nitric oxide in asthma. Can Respir J (2008) 0.76
Importance of fractional exhaled nitric oxide in diagnosis of bronchiectasis accompanied with bronchial asthma. J Thorac Dis (2016) 0.75
Breath tests in respiratory and critical care medicine: from research to practice in current perspectives. Biomed Res Int (2013) 0.75
Proposed model for Iranian national system of registration of allergy and asthma. Acta Inform Med (2013) 0.75
AIR POLLUTION INFLUENCES ON EXHALED NITRIC OXIDE AMONG PEOPLE WITH TYPE II DIABETES. Air Qual Atmos Health (2015) 0.75
Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma. J Thorac Dis (2015) 0.75
Assessing airway inflammation in clinical practice - experience with spontaneous sputum analysis. BMC Pulm Med (2008) 0.75
Electronic Noses for Well-Being: Breath Analysis and Energy Expenditure. Sensors (Basel) (2016) 0.75
Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma. Ann Transl Med (2015) 0.75
Accuracy of maximal expiratory flow-volume curve curvilinearity and fractional exhaled nitric oxide for detection of children with atopic asthma. Korean J Pediatr (2017) 0.75
Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.26
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation. Thorax (2011) 1.62
Endobronchial ultrasonography in bronchoscopic occult pulmonary lesions. J Thorac Oncol (2007) 1.53
Role of activin-A in cigarette smoke-induced inflammation and COPD. Eur Respir J (2013) 1.52
Effects of long-acting bronchodilators and placebo on histamine-induced asthma symptoms and mild bronchusobstruction. Respir Med (2005) 1.42
Preemptive therapy with steroids but not macrolides improves gas exchange in caustic-injured donor lungs. J Surg Res (2011) 1.40
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers. J Heart Lung Transplant (2005) 1.38
Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1beta-induced chemokine release in human airway smooth muscle cells. Respir Med (2003) 1.14
Nocturnal weakly acidic reflux promotes aspiration of bile acids in lung transplant recipients. J Heart Lung Transplant (2009) 1.11
The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med (2013) 1.07
The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J (2012) 1.03
Selective accumulation of langerhans-type dendritic cells in small airways of patients with COPD. Respir Res (2010) 1.01
Repeated invasive lung function measurements in intubated mice: an approach for longitudinal lung research. Lab Anim (2011) 1.00
Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome. J Heart Lung Transplant (2003) 0.97
Airway colonization and gastric aspiration after lung transplantation: do birds of a feather flock together? J Heart Lung Transplant (2008) 0.97
Lung donor selection and management. Proc Am Thorac Soc (2009) 0.97
Risk factors for airway complications within the first year after lung transplantation. Eur J Cardiothorac Surg (2007) 0.96
Interleukin-17--induced interleukin-8 release in human airway smooth muscle cells: role for mitogen-activated kinases and nuclear factor-kappaB. J Heart Lung Transplant (2005) 0.96
Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer? J Heart Lung Transplant (2010) 0.95
Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. Ann Thorac Med (2013) 0.94
The site and nature of airway obstruction after lung transplantation. Am J Respir Crit Care Med (2014) 0.89
Clinical use of biomarkers of survival in pulmonary fibrosis. Respir Res (2010) 0.89
The number of lung transplants can be safely doubled using extended criteria donors; a single-center review. Transpl Int (2010) 0.89
Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donors. J Heart Lung Transplant (2011) 0.89
Fatal Scopulariopsis infection in a lung transplant recipient: a case report. J Heart Lung Transplant (2005) 0.89
N-acetylcysteine inhibits interleukin-17-induced interleukin-8 production from human airway smooth muscle cells: a possible role for anti-oxidative treatment in chronic lung rejection? J Heart Lung Transplant (2004) 0.87
Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injury. Transpl Int (2008) 0.87
Should we ventilate or cool the pulmonary graft inside the non-heart-beating donor? J Heart Lung Transplant (2003) 0.87
Bronchoalveolar lavage neutrophilia in acute lung allograft rejection and lymphocytic bronchiolitis. J Heart Lung Transplant (2010) 0.86
Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS). Semin Respir Crit Care Med (2013) 0.86
Retrograde flush following topical cooling is superior to preserve the non-heart-beating donor lung. Eur J Cardiothorac Surg (2007) 0.86
Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ? Transplantation (2013) 0.85
Involvement of interleukin-17 during lymphocytic bronchiolitis in lung transplant patients. J Heart Lung Transplant (2013) 0.85
Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation. Transplantation (2014) 0.84
A porcine model of acute lung injury by instillation of gastric fluid. J Surg Res (2010) 0.84
How long can we preserve the pulmonary graft inside the nonheart-beating donor? Ann Thorac Surg (2004) 0.83
A decade of extended-criteria lung donors in a single center: was it justified? Transpl Int (2014) 0.83
Bronchial carcinoma after lung transplantation: a single-center experience. J Heart Lung Transplant (2012) 0.83
Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection. Transplantation (2012) 0.83
N-acetyl cysteine attenuates the inflammatory response in warm ischemic pig lungs. J Surg Res (2007) 0.81
De novo or persistent pseudomonal airway colonization after lung transplantation: importance for bronchiolitis obliterans syndrome? Transplantation (2008) 0.81
Activation of the hexose monophosphate shunt in rat type II pneumocytes as an early marker of oxidative stress caused by cobalt particles. Arch Toxicol (2002) 0.81
Azithromycin decreases MMP-9 expression in the airways of lung transplant recipients. Transpl Immunol (2011) 0.81
N-acetyl cysteine pre-treatment attenuates inflammatory changes in the warm ischemic murine lung. J Heart Lung Transplant (2007) 0.81
Non-heart-beating donors. Semin Thorac Cardiovasc Surg (2004) 0.81
Nebulized N-acetyl cysteine protects the pulmonary graft inside the non-heart-beating donor. J Heart Lung Transplant (2005) 0.80
Vitamin D deficiency in lung transplant patients: is it important? Transplantation (2012) 0.80
Azithromycin: a plea for multicenter randomized studies in lung transplantation. Am J Respir Crit Care Med (2005) 0.80
Smoking resumption after lung transplantation: standardised screening and importance for long-term outcome. Eur Respir J (2013) 0.80
Macrolide therapy targets a specific phenotype in respiratory medicine: from clinical experience to basic science and back. Inflamm Allergy Drug Targets (2008) 0.79
An algorithm to tackle acute exacerbations in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2008) 0.79
Evaluating lung injury at increasing time intervals in a murine brain death model. J Surg Res (2013) 0.78
Thin-section computed tomography findings before and after azithromycin treatment of neutrophilic reversible lung allograft dysfunction. Eur Radiol (2011) 0.78
Heterogeneity of chronic lung allograft dysfunction: insights from protein expression in broncho alveolar lavage. J Heart Lung Transplant (2011) 0.78
Interleukin-17 and neutrophils are increased in BAL fluid during acute lung rejection. Chest (2007) 0.78
Exhaled carbon monoxide as a noninvasive marker of airway neutrophilia after lung transplantation. Transplantation (2009) 0.78
Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation. Transpl Int (2014) 0.78
Retrograde flush following warm ischemia in the non-heart-beating donor results in superior graft performance at reperfusion. J Surg Res (2008) 0.78
Chronic lung allograft dysfunction: evolving practice. Curr Opin Organ Transplant (2015) 0.77
Azithromycin attenuates fibroblast growth factors induced vascular endothelial growth factor via p38(MAPK) signaling in human airway smooth muscle cells. Cell Biochem Biophys (2013) 0.77
Transforming growth factor-beta 1 induces angiogenesis in vitro via VEGF production in human airway smooth muscle cells. Indian J Biochem Biophys (2011) 0.77
Circulating and intrapulmonary C-reactive protein: a predictor of bronchiolitis obliterans syndrome and pulmonary allograft outcome. J Heart Lung Transplant (2009) 0.77
Genetic variation in interleukin-17 receptor A is functionally associated with chronic rejection after lung transplantation. J Heart Lung Transplant (2013) 0.77
Broncho-alveolar lavage fluid recovery correlates with airway neutrophilia in lung transplant patients. Respir Med (2007) 0.76
Comparative study of donor lung injury in heart-beating versus non-heart-beating donors. Eur J Cardiothorac Surg (2006) 0.76
Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction. Transplantation (2015) 0.76
Donor cause of brain death and related time intervals: does it affect outcome after lung transplantation? Eur J Cardiothorac Surg (2011) 0.76
Short- and Long-Term Outcome After Lung Transplantation From Circulatory-Dead Donors: A Single-Center Experience. Transplantation (2017) 0.76
IL-1beta in bronchial lavage fluid is a non-invasive marker that predicts the viability of the pulmonary graft from the non-heart-beating donor. J Heart Lung Transplant (2005) 0.76
Long-term preservation with interim evaluation of lungs from a non-heart-beating donor after a warm ischemic interval of 90 minutes. Ann Surg (2003) 0.75
Inhaled cyclosporine in lung transplantation. N Engl J Med (2006) 0.75
Does vitamin D really impact survival after lung transplantation? J Heart Lung Transplant (2012) 0.75
Phenotyping BOS could improve understanding of mechanisms involved. J Heart Lung Transplant (2010) 0.75
A model of ex vivo perfusion of porcine donor lungs injured by gastric aspiration: a step towards pretransplant reconditioning. J Surg Res (2011) 0.75
Integration of clinical, radiological, and histopathological data in the diagnosis of diffuse parenchymal lung diseases. Am J Respir Crit Care Med (2009) 0.75
ABPA: does it really exist after lung transplantation? J Heart Lung Transplant (2009) 0.75
Single-lung transplantation: does side matter? Eur J Cardiothorac Surg (2011) 0.75
Genetic variation in caveolin-1 affects survival after lung transplantation. Transplantation (2014) 0.75
Impact of warm ischemia on different leukocytes in bronchoalveolar lavage from mouse lung: possible new targets to condition the pulmonary graft from the non-heart-beating donor. J Heart Lung Transplant (2006) 0.75
Fluoro-D-glucose-micro positron emission tomography as a diagnostic tool to confirm brain death in a murine donor lung injury model. J Surg Res (2012) 0.75
The role of leukocyte depletion in ex vivo evaluation of pulmonary grafts from (non-)heart-beating donors. Perfusion (2003) 0.75
Primary cryptococcal cellulitis in a lung transplant recipient. J Heart Lung Transplant (2007) 0.75
Newer modes of treating interstitial lung disease. Curr Opin Pulm Med (2011) 0.75
The mode of death in the non-heart-beating donor has an impact on lung graft quality. Eur J Cardiothorac Surg (2009) 0.75
Hypogonadism in male outpatients with sarcoidosis. Respir Med (2007) 0.75
A porcine model to study ex vivo reconditioning of injured donor lungs. J Surg Res (2009) 0.75
An international ISHLT/ATS/ERS clinical practice guideline: summary for clinicians. Bronchiolitis obliterans syndrome complicating lung transplantation. Ann Am Thorac Soc (2015) 0.75
Sleep Disordered Breathing After Lung Transplantation: A Prospective Study. Transplantation (2015) 0.75